September 12, 2016 By BRAD PERRIELLO   A federal appeals court today overturned the enhanced damages and attorney fees awarded in Stryker‘s (NYSE:SYK) $70 million patent infringement win over Zimmer Biomet (NYSE:ZBH), but upheld its prior ruling that patents were valid and infringed. The case was sent back to the U.S. Court of Appeals for the Federal Circuit in June, when the […]